Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Pyxis Oncology (PYXS) Revenue (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Revenue for 2 consecutive years, with $11.0 million as the latest value for Q4 2025.

  • Quarterly Revenue changed N/A to $11.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $13.9 million through Dec 2025, down 14.17% year-over-year, with the annual reading at $13.9 million for FY2025, 14.17% down from the prior year.
  • Revenue for Q4 2025 was $11.0 million at Pyxis Oncology, up from $2.8 million in the prior quarter.
  • The five-year high for Revenue was $16.1 million in Q1 2024, with the low at $2.8 million in Q2 2025.